Literature DB >> 19114902

The vasopressin and copeptin response to infection, severe sepsis, and septic shock.

Stefan Jochberger1, Jakob Dörler, Günter Luckner, Viktoria D Mayr, Volker Wenzel, Hanno Ulmer, Nils G Morgenthaler, Walter R Hasibeder, Martin W Dünser.   

Abstract

OBJECTIVE: To compare the course of arginine vasopressin (AVP) and copeptin plasma concentrations between patients with infection, severe sepsis, and septic shock.
DESIGN: Prospective, closed-cohort study.
SETTING: Twelve-bed general and surgical intensive care unit and 33-bed internal medicine ward in a university hospital. PATIENTS: Ten patients with infection, 22 with severe sepsis, and 28 with septic shock.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Hemodynamic, laboratory and clinical data were recorded daily during the first 7 days after intensive care unit or hospital admission. Parallel thereto, blood was withdrawn to determine plasma AVP (radioimmunoassay) and copeptin (immunoluminometric assay) concentrations. Standard tests, a mixed effects model, and a linear regression analysis were used for statistical analysis. The AVP response was different between the three study groups (p < 0.001) but did not change over time (p = 0.12). Although patients with severe sepsis and septic shock had higher AVP levels than did patients with infection (both p < 0.001), no difference in AVP concentrations was seen between severe sepsis and septic shock patients (p = 0.98). No difference in AVP was observed between survivors and nonsurvivors at day 28 (p = 0.87). In patients with severe sepsis, serum osmolarity (p < 0.001), arterial pH (p = 0.001), lactate (p < 0.001), and Pao2 (p = 0.04) were associated with the course of AVP plasma levels, whereas it was serum osmolarity alone in patients with septic shock (p = 0.03). Plasma AVP concentrations correlated with copeptin (r = .614, p < 0.001), but this correlation was influenced by continuous veno-venous hemofiltration (p = 0.002).
CONCLUSIONS: Severe sepsis induced a stronger AVP response than infection without systemic inflammation. However, the lack of a difference in AVP plasma concentrations between patients with and without shock indicates that the AVP system does not function normally in severe sepsis. Our data support the hypothesis that impaired AVP response is at least partially responsible for the failure to restore vascular tone in septic shock.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19114902     DOI: 10.1097/CCM.0b013e3181957532

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  26 in total

1.  Changes in copeptin and bioactive vasopressin in runners with and without hyponatremia.

Authors:  Tamara Hew-Butler; Martin D Hoffman; Kristin J Stuempfle; Ian R Rogers; Nils G Morgenthaler; Joseph G Verbalis
Journal:  Clin J Sport Med       Date:  2011-05       Impact factor: 3.638

2.  Increased levels of pro-AVP and pro-ADM in septic shock patients: what could it mean?

Authors:  Antoine Roch
Journal:  Intensive Care Med       Date:  2009-08-07       Impact factor: 17.440

3.  Influences of hydrocortisone therapy on arginine vasopressin plasma levels in septic shock.

Authors:  Stefan Jochberger; Martin W Dünser
Journal:  Wien Klin Wochenschr       Date:  2011-04-11       Impact factor: 1.704

4.  Angiotensin AT1A receptors expressed in vasopressin-producing cells of the supraoptic nucleus contribute to osmotic control of vasopressin.

Authors:  Jeremy A Sandgren; Danny W Linggonegoro; Shao Yang Zhang; Sarah A Sapouckey; Kristin E Claflin; Nicole A Pearson; Mariah R Leidinger; Gary L Pierce; Mark K Santillan; Katherine N Gibson-Corley; Curt D Sigmund; Justin L Grobe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-01-24       Impact factor: 3.619

5.  The selective vasopressin type 1a receptor agonist selepressin (FE 202158) blocks vascular leak in ovine severe sepsis*.

Authors:  Marc O Maybauer; Dirk M Maybauer; Perenlei Enkhbaatar; Régent Laporte; Halina Wiśniewska; Lillian D Traber; ChiiDean Lin; Juanjuan Fan; Hal K Hawkins; Robert A Cox; Kazimierz Wiśniewski; Claudio D Schteingart; Donald W Landry; Pierre J-M Rivière; Daniel L Traber
Journal:  Crit Care Med       Date:  2014-07       Impact factor: 7.598

Review 6.  The Emerging Role of Copeptin.

Authors:  R Jalleh; D J Torpy
Journal:  Clin Biochem Rev       Date:  2021-02

7.  Copeptin as a marker of relative arginine vasopressin deficiency after pediatric cardiac surgery.

Authors:  Christopher W Mastropietro; Meredith Mahan; Kevin M Valentine; Jeff A Clark; Patrick C Hines; Henry L Walters; Ralph E Delius; Ashok P Sarnaik; Noreen F Rossi
Journal:  Intensive Care Med       Date:  2012-10-24       Impact factor: 17.440

8.  Vasopressin and copeptin levels in children with sepsis and septic shock.

Authors:  Jan Hau Lee; Yoke Hwee Chan; Oi Fah Lai; Janil Puthucheary
Journal:  Intensive Care Med       Date:  2013-01-24       Impact factor: 17.440

9.  Hormonal responses upon return of spontaneous circulation after cardiac arrest: a retrospective cohort study.

Authors:  Jin Joo Kim; Sung Youl Hyun; Seong Youn Hwang; Young Bo Jung; Jong Hwan Shin; Yong Su Lim; Jin Seong Cho; Hyuk Jun Yang; Gun Lee
Journal:  Crit Care       Date:  2011-02-07       Impact factor: 9.097

Review 10.  Bench-to-bedside review: Vasopressin in the management of septic shock.

Authors:  James A Russell
Journal:  Crit Care       Date:  2011-08-11       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.